首頁 > 市場調查報告書 > 食物/飲料

動物飼料

市場調查報告書

商品編碼

1448009

飼料抗生素市場 - 2023-2030

Feed Antibiotics Market - 2023-2030

出版日期: 2024年03月08日 | 出版商:

DataM Intelligence | 英文 181 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年，全球飼料抗生素市場規模達28億美元，預計2030年將達到392萬美元，2023-2030年預測期間CAGR為4.3%。

全球人口的成長和許多地區收入水準的提高導致肉類和乳製品消費量增加。據糧農組織稱，到 2030 年，全球人均肉類消費量預計將每年成長 0.3%，達到零售重量當量 35.4 公斤。因此，對動物飼料（包括促進牲畜生長和健康的抗生素）的需求將會增加。

飼料抗生素通常用於提高牲畜生長速度並提高動物養殖中的飼料效率。透過促進更快的生長和有效的養分利用，農民可以更有效地滿足全球對肉類和動物產品日益成長的需求。這種做法旨在最大限度地提高集約化農業系統的生產力。因此，人們對使用飼料抗生素的好處的認知不斷提高是推動市場成長的關鍵趨勢。

四環素類藥物在全球飼料抗生素市場中發揮著至關重要的作用，由於其廣泛用於促進牲畜生長和預防疾病，因此佔了三分之一的佔有率。同時，亞太地區佔據了同樣重要的三分之一佔有率，這主要是由於對肉類和乳製品的需求不斷成長所推動的。根據《中國簡報》報道，2022年，中國人均豬肉消費量將超過5300萬噸，牛肉和小牛肉消費量將超過1000萬噸，成為全球最大的肉類消費國之一。

動力學

對動物性食品的需求不斷成長

隨著全球人口的成長和收入的增加，對肉類、乳製品和雞蛋的需求不斷成長。據糧農組織稱，2018 年至 2030 年間，全球動物蛋白消費量預計將增加 14%。到 2030 年，綿羊、牛肉、豬肉和家禽肉中的蛋白質預計將增加 17.8%、5.9%。分別為%、 13.1% 和15.7%。為了保持這些動物的健康並促進生長，許多農民歷來使用抗生素作為飼料添加劑，這推動了其需求。

抗生素在畜牧業中發揮多方面的作用，促進生長、預防疾病和促進治療。工業化農業的擁擠和壓力條件創造了疾病可以在動物之間迅速傳播的環境。抗生素有助於預防這些疾病並降低牲畜死亡率，確保動物性食品的穩定供應。農民受益於這種效率，因為它減少了飼養動物所需的時間和資源。

增加動物保健支出投資

各國政府和私人投資者越來越認知到畜牧業的重要性，並投資於現代化畜牧生產設施，加強動物健康管理等。2020 年2 月，Elanco Animal Health Incorporated 宣布與默克動物保健公司(Merck Animal Health) 達成協議，轉讓Vecoxan 在全球範圍內的權利。5500 萬美元全現金安排。 Vecoxan 用於預防和治療犢牛和羔羊的球蟲病。這些類型的投資反過來推動了飼料抗生素市場的成長

抗生素在動物飼料中對於預防和控制疾病至關重要。健康的動物不僅生長得更快，而且生產效率更高，這對於滿足對動物產品不斷成長的需求至關重要。抗生素在減少人口稠密的畜牧設施中疾病爆發方面發揮著至關重要的作用，從而改善整體健康狀況並提高生產力水平。因此，隨著消費者對動物福利和牲畜抗生素使用意識的不斷增強，對來自負責任地使用抗生素飼養的動物的產品的需求不斷成長。

抗生素抗藥性不斷增強

抗生素的過度使用和濫用，包括在畜牧業的使用，導致了抗生素抗藥性細菌的發展。這些抗藥性病原體可以感染動物，並有可能透過食物鏈或環境污染傳播給人類，造成重大的公共衛生風險。美國肉類研究所聲稱，食用接受抗生素治療的動物的肉會導致人類抗菌素抗藥性（對某些抗生素產生抗藥性）。

世界各地的監管機構越來越關注抗生素抗藥性及其對人類健康的影響。因此，許多國家推出了更嚴格的法規來管理畜牧業中抗生素的使用。例如，2022 年 1 月 28 日，歐盟實施了一項新法律，禁止對養殖動物進行常規飼餵抗生素。此類法規通常會限制可以使用的抗生素類型，從而限制畜牧業抗生素市場的成長。

Growing global populations and increasing income levels in many regions were leading to higher meat and dairy consumption. According to FAO, worldwide per capita meat consumption is expected to rise by 0.3% pa to 35.4 kg in retail weight equivalent by 2030. As a result, there is a greater demand for animal feed, including antibiotics to promote livestock growth and health.

Feed antibiotics were commonly employed to boost livestock growth rates and improve feed efficiency in animal farming. By promoting faster growth and efficient nutrient utilization, farmers could meet the increasing global demand for meat and animal products more effectively. This practice aimed to maximize productivity within intensive farming systems. Hence, rising awareness about the benefits of using feed antibiotics acts as a key trend for boosting market growth.

Tetracyclines play a crucial role in the global feed antibiotics market, constituting a significant one-third share due to their widespread use for promoting livestock growth and preventing diseases. At the same time, the Asia-Pacific region holds an equally substantial one-third share, mainly driven by the increasing demand for meat and dairy products. According to China Briefing, with an average per capita consumption of over 53 million tons of pork and 10 million tons of beef and veal, China was among the world's largest meat consumers in 2022.

Dynamics

Rising Demand for Animal-derived Food Products

There is a rising demand for meat, dairy, and eggs, as global populations grow and incomes rise. According to FAO, the consumption of animal proteins worldwide is anticipated to increase by 14% between 2018 and 2030. By 2030, it is anticipated that the protein available from meat from sheep, beef, pork, and poultry will increase by 17.8%, 5.9%, 13.1%, and 15.7%, respectively. To keep these animals healthy and promote growth, many farmers have historically used antibiotics as feed additives which drives its demand.

Antibiotics in animal agriculture serve a multifaceted role, promoting growth, preventing diseases, and facilitating treatment. The crowded and stressful conditions of industrial farming create an environment where diseases can quickly spread among animals. Antibiotics help prevent these diseases and reduce livestock mortality rates, ensuring a stable supply of animal-derived food products. Farmers benefit from this efficiency as it reduces the time and resources needed to raise animals for food.

Increasing Investment in Animal Health Expenditure

Governments and private investors are increasingly recognizing the importance of the livestock sector and are investing in modernizing livestock production facilities enhancing animal health management etc. In February 2020, Elanco Animal Health Incorporated announced an agreement with Merck Animal Health to transfer worldwide rights for the Vecoxan for USD 55 million in an all-cash arrangement. Vecoxan is used for the prevention and treatment of coccidiosis in calves and lambs. These types of investments in turn drive the feed antibiotics market growth

Antibiotics are crucial in animal feed for preventing and managing diseases. Healthy animals not only grow faster but also produce more efficiently, which is essential to meet the growing demand for animal products. Antibiotics play a vital role in minimizing disease outbreaks in densely populated livestock facilities, resulting in improved overall health and higher productivity levels. Hence with the growing consumer awareness of animal welfare, and antibiotic use in livestock there is a growing demand for products from animals raised with responsible antibiotic use.

Growing Resistance to Antibiotics

Overuse and misuse of antibiotics, including their use in animal agriculture, have led to the development of antibiotic-resistant bacteria. These resistant pathogens can infect animals and have the potential to transfer to humans through the food chain or environmental contamination, creating a significant public health risk. The American Meat Institute claims that eating meat from an animal that has received antibiotic treatment results in human antimicrobial resistance (resistance to certain antibiotics).

Regulatory bodies worldwide are increasingly concerned about antibiotic resistance and its impact on human health. Consequently, many countries have introduced stricter regulations governing antibiotic use in livestock farming. For instance, on January 28, 2022, the European Union implemented a new law prohibiting the routine feeding of antibiotics to farmed animals. Such regulations often restrict the types of antibiotics that can be employed, thereby constraining the growth of the antibiotic market in animal agriculture.

Segment Analysis

The global feed antibiotics market is segmented based on type, animal, mode of delivery, end-user and region.

Rising Demand Tetracyclines for Effectiveness against Various Bacteria

Tetracyclines, a class of antibiotics known for their wide-ranging effectiveness against various bacteria, play a crucial role in preventing and treating bacterial infections in animals. They excel in managing respiratory, gastrointestinal, and skin infections in animals. Regulatory agencies, including the FDA, have approved numerous tetracycline antibiotics for use in animal agriculture, underscoring their safety and suitability for this purpose. This regulatory approval instills confidence in their safety and efficacy.

Tetracyclines have a long history of successful use in veterinary medicine. Their effectiveness in controlling and preventing. Their versatile administration methods, including through feed, water, or injections, provide farmers with the flexibility to cater to the specific needs of animals and the diseases they face, making them a convenient and trusted option.

Source: DataM Intelligence Analysis (2023)

Geographical Penetration

Asia-Pcific's Growing Feed Industry

The region has embraced modern and intensive farming practices to maximize animal production efficiency. According to a study published in February 2020 by Dongguan University of Technology, Dongguan, China, in-feed antibiotic use altered behaviors of Oxytetracycline, sulfamerazine, and ciprofloxacin, as well as related antibiotic resistance genes during the composting of swine manure.

Asia-Pacific has experienced significant population growth, urbanization, and rising incomes. This has led to increased demand for animal-based protein products, such as meat, milk, and eggs. The Department of Animal Husbandry and Dairying reports that India is the world's top producer of milk. Milk production increased by 5.81% annually between 2019-2020 and 2020-21, reaching 198.44 million tonnes and 209.96 million tonnes, respectively. This rising demand for animal-derived products needs large amounts of feed antibiotics.

Key players in the feed and agriculture sectors have established a strong presence in the Asia Pacific, boosting market growth. The key players of feed antibiotics present in Asia-Pacific are Bayer Health Care AG, Virbac Animal Health, Merck Animal Health, Elanco Animal Health, etc. These companies are investing in R&D infrastructure and continuously introducing various feed additives including feed yeast. Hence, the presence of major companies acts as a key trend for the feed yeast market growth in that region.

Source: DataM Intelligence Analysis (2023)

Competitive Landscape

The major global players include Merck & Co., Inc, Zoetis Services LLC, Virbac, Phibro Animal Health Corporation, Vetoquinol, Ceva, Kyoritsuseiyaku Corporation, Inovet, MEGAMIX and Dechra Pharmaceuticals PLC.

COVID-19 Impact Analysis

COVID Impact

The pandemic disrupted global supply chains, affecting the production and distribution of feed antibiotics. This led to shortages and delays in the availability of feed antibiotics in some regions, impacting farmers' ability to maintain animal health. COVID-19 heightened consumer awareness of food safety and hygiene. This led to increased demand for products from animals raised with responsible antibiotic use or raised without antibiotics. As a result, some farmers and producers shifted towards antibiotic-free or reduced-antibiotic practices.

Concerns about antibiotic resistance have led to increased regulatory scrutiny of antibiotic use in animal agriculture. Some regions implemented stricter regulations during the pandemic, further influencing antibiotic use practices in livestock. The economic challenges brought by the pandemic, including reduced demand for certain animal products and increased production costs, made farmers more conscious of their expenses. This prompted some to reevaluate their antibiotic use and explore cost-effective alternatives.

Russia- Ukraine War Impact

Ukraine is a significant producer of agricultural commodities, including grains and animal feed ingredients. The conflict has disrupted the agricultural supply chain in the region, potentially affecting the availability and prices of feed ingredients used in animal agriculture, including those related to feed antibiotics. The conflict disrupted international trade routes and agreements, affecting the export and import of animal products and feed ingredients.

The war has led to economic instability in Ukraine and neighboring regions. Economic uncertainties affect consumer demand for animal products, which in turn can influence the production practices and antibiotic use in animal agriculture. As a response to supply chain disruptions caused by the conflict, some regions or countries may seek to diversify their sources of feed ingredients and animal products. This diversification can impact the distribution and use of feed antibiotics.

By Type

Tetracyclines
Penicillins
Sulfonamides
Macrolides
Aminoglycosides
Cephalosporins
Others

By Animal

Ruminants
Poultry
Swine
Aquaculture
Horses
Pets
Others

By Mode of Delivery

Premixes
Oral Powder
Oral Solution
Injection
Others

By End-User

Veterinary Hospitals
Homecare
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In July 2022, Virbac, dedicated to animal health, introduced TENOTRYL (enrofloxacin) injectable solution in the United States and expanded its product line to offer veterinarians and their clients, cattle and swine producers, a strong bench of new alternatives to enhance the health of livestock and, ultimately, their profitability.
In November 2021, Kemin, a manufacturer of ingredients for several industries, including human/animal health and nutrition, pet food, aquaculture etc. introduced a new product in Europe called TOXFIN CARE. This product was designed to protect animal organs and tissue from potential mycotoxin harm to prevent performance and productivity loss.
In July 2020, Trianni and Zoetis, an animal health company, announced an agreement, to create a transgenic antibody discovery platform for use in animal health.

Why Purchase the Report?

To visualize the global feed antibiotics market segmentation based on type, animal, mode of delivery, end-user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of Feed Antibiotics market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global feed antibiotics market report would provide approximately 77 tables, 69 figures and 181 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1.Methodology and Scope

1.1.Research Methodology
1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

3.1.Snippet by Type
3.2.Snippet by Animal
3.3.Snippet by Mode of Delivery
3.4.Snippet by End-user
3.5.Snippet by Region

4.Dynamics

4.1.Impacting Factors
- 4.1.1.Drivers
  - 4.1.1.1.Rising Demand for Animal-derived Food Products
  - 4.1.1.2.Increasing Investment in Animal Health Expenditure
- 4.1.2.Restraints
  - 4.1.2.1.Growing Resistance to Antibiotics
- 4.1.3.Opportunity
- 4.1.4.Impact Analysis

5.Industry Analysis

5.1.Porter's Five Force Analysis
5.2.Supply Chain Analysis
5.3.Pricing Analysis
5.4.Regulatory Analysis

6.COVID-19 Analysis

6.1.Analysis of COVID-19
- 6.1.1.Scenario Before COVID
- 6.1.2.Scenario During COVID
- 6.1.3.Scenario Post COVID
6.2.Pricing Dynamics Amid COVID-19
6.3.Demand-Supply Spectrum
6.4.Government Initiatives Related to the Market During Pandemic
6.5.Manufacturers Strategic Initiatives
6.6.Conclusion

7.By Type

7.1.Introduction
- 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2.Market Attractiveness Index, By Type
7.2.Tetracyclines*
- 7.2.1.Introduction
- 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3.Penicillins
7.4.Sulfonamides
7.5.Macrolides
7.6.Aminoglycosides
7.7.Cephalosporins
7.8.Others

8.By Animal

8.1.Introduction
- 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
- 8.1.2.Market Attractiveness Index, By Animal
8.2.Ruminants*
- 8.2.1.Introduction
- 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3.Poultry
8.4.Swine
8.5. Aquaculture
8.6.Horses
8.7.Pets
8.8.Others

9.By Mode of Delivery

9.1.Introduction
- 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 9.1.2.Market Attractiveness Index, By Mode of Delivery
9.2.Premixes*
- 9.2.1.Introduction
- 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3.Oral Powder
9.4.Oral Solution
9.5.Injection
9.6.Others

10.By End-User

10.1.Introduction
- 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2.Market Attractiveness Index, By End-User
10.2.Veterinary Hospitals*
- 10.2.1.Introduction
- 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3.Homecare
10.4.Others

11.By Region

11.1.Introduction
- 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2.Market Attractiveness Index, By Region
11.2.North America
- 11.2.1.Introduction
- 11.2.2.Key Region-Specific Dynamics
- 11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
- 11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1.U.S.
  - 11.2.7.2.Canada
  - 11.2.7.3.Mexico
11.3.Europe
- 11.3.1.Introduction
- 11.3.2.Key Region-Specific Dynamics
- 11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
- 11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1.Germany
  - 11.3.7.2.UK
  - 11.3.7.3.France
  - 11.3.7.4.Italy
  - 11.3.7.5.Russia
  - 11.3.7.6.Rest of Europe
11.4.South America
- 11.4.1.Introduction
- 11.4.2.Key Region-Specific Dynamics
- 11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
- 11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1.Brazil
  - 11.4.7.2.Argentina
  - 11.4.7.3.Rest of South America
11.5.Asia-Pacific
- 11.5.1.Introduction
- 11.5.2.Key Region-Specific Dynamics
- 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
- 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1.China
  - 11.5.7.2.India
  - 11.5.7.3.Japan
  - 11.5.7.4.Australia
  - 11.5.7.5.Rest of Asia-Pacific
11.6.Middle East and Africa
- 11.6.1.Introduction
- 11.6.2.Key Region-Specific Dynamics
- 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
- 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12.Competitive Landscape

12.1.Competitive Scenario
12.2.Market Positioning/Share Analysis
12.3.Mergers and Acquisitions Analysis

13.Company Profiles

13.1.Merck & Co., Inc.*
- 13.1.1.Company Overview
- 13.1.2.Product Portfolio and Description
- 13.1.3.Financial Overview
- 13.1.4.Recent Developments
13.2.Zoetis Services LLC.
13.3.Virbac.
13.4.Phibro Animal Health Corporation
13.5.Vetoquinol
13.6.Ceva
13.7.Kyoritsuseiyaku Corporation
13.8.Inovet
13.9.MEGAMIX
13.10.Dechra Pharmaceuticals PLC LIST NOT EXHAUSTIVE

14.Appendix

14.1.About Us and Services
14.2.Contact Us

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

飼料抗生素市場 - 2023-2030

Feed Antibiotics Market - 2023-2030

目錄

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動力學

第 5 章：產業分析

第 6 章：COVID-19 分析

第 7 章：按類型

第 8 章：依動物分類

第 9 章：依交付方式

第 10 章：最終用戶

第 11 章：按地區

第 12 章：競爭格局

第 13 章：公司簡介

第 14 章：附錄